Italia markets close in 2 hours 14 minutes

ILMN Sep 2024 185.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,80000,0000 (0,00%)
In data: 10:41AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,8000
Aperto1,8000
Denaro0,0000
Lettera0,0000
Prezzo d'esercizio185,00
Scadenza2024-09-20
Min-Max giorno1,8000 - 1,8000
Contratto - Min-MaxN/D
Volume1
Open Interest101
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera